Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Monash IVF Group Ltd ( (AU:MVF) ) just unveiled an update.
Monash IVF Group Ltd announced the appointment of Dwayne Crombie as a director, effective from November 24, 2025. The initial director’s interest notice reveals that Crombie currently holds no relevant interests in the company’s securities, indicating a neutral impact on the company’s operations and market positioning.
The most recent analyst rating on (AU:MVF) stock is a Buy with a A$0.90 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Ltd operates in the healthcare industry, focusing on fertility treatments and reproductive health services. The company provides a range of assisted reproductive technologies and services to support individuals and couples seeking to conceive.
Average Trading Volume: 2,325,118
Technical Sentiment Signal: Sell
Current Market Cap: A$237.7M
For a thorough assessment of MVF stock, go to TipRanks’ Stock Analysis page.